We have received important clarifying advice on the ongoing international Sinemet supply shortage. The aim is to provide an accurate, evidence-based guide for general clinicians to appropriately substitute the Sinemet formulation. The advice is a joint position statement by the Australasian Neuroscience Nurses Association (ANNA) Movement Disorder Chapter (MDC) committee in collaboration with the Movement Disorder Society of Australia and New Zealand (MDSANZ). It is published on the ANNA website here.
You can also view it on our website here:
Note that there is also useful information in our earlier update of April 2019 also to be found in this news blog.